Advertisement

<a href="//cdm-d.openx.net/w/1.0/rc?cs=ede153ebee&cb=INSERT_RANDOM_NUMBER_HERE"> <img src="//cdm-d.openx.net/w/1.0/ai?auid=538187993&cs=ede153ebee&cb=INSERT_RANDOM_NUMBER_HERE" border="0" alt=""></a>

#Descovy

Gilead Files For FDA Approval of Integrase Inhibitor–Based HIV Regimen

The single-tablet regimen includes the experimental bictegravir plus the contents of Descovy (emtricitabine/tenofovir alafenamide).

Prevention: New PrEP Trial

New trial compares Descovy to Truvada.

Descovy

FDA OKs Gilead’s Descovy (Not for PrEP)

The U.S. Food and Drug Administration approved Gilead Sciences’ Descovy for the treatment of HIV in combination with other antiretrovirals.

FDA OKs Gilead’s Descovy, a Safer Version of Truvada, for HIV Treatment Only (Not for PrEP)

The FDA has approved Gilead Sciences’ fixed-dose combination tablet Descovy (emtricitabine/tenofovir alafenamide) for HIV treatment.

Advertisement

<a href="//cdm-d.openx.net/w/1.0/rc?cs=ede153ebee&cb=INSERT_RANDOM_NUMBER_HERE"> <img src="//cdm-d.openx.net/w/1.0/ai?auid=538187994&cs=ede153ebee&cb=INSERT_RANDOM_NUMBER_HERE" border="0" alt=""></a>